Clinical markers of slow healing and relapsing gastric ulcer.

The aim of the study was to identify the clinical markers useful in characterising slow healing and relapsing gastric ulcer patients. Ninety nine subjects entered the short term and 79 the long term study (12 months). The following parameters were taken into account: therapy, sex, age, smoking habit, alcohol consumption, analgesic intake, peptic ulcer family history and onset of the disease. Results of the studies were analysed by means of chi 2 test and logistic regression, both in stepwise and in specifying models. Cigarette smoking was found to be the most important risk factor of non-healing (p = 0.04). In women with late onset of the disease, cigarette smoking identified the gastric ulcer subjects at higher risk of non-healing with a predictive probability of 0.4679. Age under 50 years was found to be the most important risk factor of relapsing throughout the entire 12 month follow up period (p = 0.025). In those under 50 years, cigarette smoking and negative peptic ulcer family history in combination, identified the gastric ulcer subjects at higher risk of relapsing, the predicted probability being 0.6027. It is concluded that cigarette smoking is the most important risk factor for non-healing and those who relapse under the age of 50. The possibility of singling out categories of patients more prone not to heal and to relapse suggests new strategies in the management of gastric ulcer disease.

[1]  A. Piccoli,et al.  Is maximal acid output useful in identifying relapsing duodenal ulcer patients? , 1985, Journal of clinical gastroenterology.

[2]  W. Mcadam,et al.  Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence. , 1985, Gut.

[3]  A. Piccoli,et al.  Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers. , 1984, The American journal of gastroenterology.

[4]  D. Graham,et al.  Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. , 1984, The New England journal of medicine.

[5]  Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. The Belgian Peptic Ulcer Study Group. , 1984, Gut.

[6]  T. Omae,et al.  Factors influencing the healing rate of gastric ulcer in hospitalised subjects. , 1984, Gut.

[7]  S. Jain,et al.  Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence. , 1984, Scandinavian journal of gastroenterology.

[8]  W. Reichel,et al.  Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study. , 1983, Gut.

[9]  L. Barbara,et al.  Ranitidine vs cimetidine: short-term treatment of gastric ulcer. , 1983, Hepato-gastroenterology.

[10]  D. Piper,et al.  A two-year prospective controlled study of maintenance cimetidine and gastric ulcer. , 1983, Gastroenterology.

[11]  J. Elashoff,et al.  Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial. , 1983, The New England journal of medicine.

[12]  G. Pilon,et al.  Effect of ranitidine on healing of peptic ulcer: a 2-month study. , 1983, The American journal of gastroenterology.

[13]  M. Korman,et al.  Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. , 1983, Gastroenterology.

[14]  J. Elashoff,et al.  Recurrent ulcer after successful treatment with cimetidine or antacid. , 1983, Gastroenterology.

[15]  M. Classen,et al.  Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study. , 1983, Scandinavian journal of gastroenterology. Supplement.

[16]  J. Kellow,et al.  Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. A double-blind trial. , 1983, Digestion.

[17]  R. Möllby,et al.  Occurrence of Clostridium difficile toxin in inflammatory bowel disease. , 1983, Scandinavian journal of gastroenterology.

[18]  R. Gugler,et al.  Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. , 1982, Gut.

[19]  M. Korman,et al.  Ranitidine in duodenal ulcer , 1982, Digestive diseases and sciences.

[20]  D. R. Sutton Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. , 1982, Gut.

[21]  W. Mcadam,et al.  Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. , 1982, Gut.

[22]  A. Sonnenberg,et al.  Predictors of duodenal ulcer healing and relapse. , 1981, Gastroenterology.

[23]  J. Pachlewski,et al.  Multicentre double blind clinical trial on ranitidine for gastroduodenal ulcer. , 1981, Hepato-gastroenterology.

[24]  Sung Gyoo Park Clinical Tests of Gastric Secretion. History, Methodology and Interpretation: , 1980 .

[25]  D. Piper,et al.  The healing rate of chronic gastric ulcer in patients admitted to hospital. , 1980, Scandinavian journal of gastroenterology.

[26]  J. Hunter,et al.  Cimetidine in the prevention of gastric ulcer relapse. , 1979, Postgraduate medical journal.

[27]  H. Wulff,et al.  Prophylactic effect of cimetidine in gastric ulcer patients. , 1979, Scandinavian journal of gastroenterology.

[28]  B. E. Walker,et al.  Cimetidine: an advance in gastric ulcer treatment? , 1978, British medical journal.

[29]  M. Lacruz,et al.  Cimetidine is effective in the treatment of gastric ulcer , 1978 .

[30]  D. Piper,et al.  Effect of ulcer healing on the prognosis of chronic gastric ulcer , 1978, Gut.

[31]  B. Fleshler,et al.  Cimetidine and placebo in the treatment of benign gastric ulcer: A multicenter double blind study , 1978 .

[32]  T. Nakajima Studies on factors affecting healing of gastric ulcer. A prospective, cooperative study in Japan. , 1976, The American journal of gastroenterology.

[33]  D. Piper,et al.  Factors relevant to the prognosis of chronic gastric ulcer. , 1975, Gut.

[34]  D. Piper,et al.  Factors influencing the healing rate of chronic gastric ulcer , 1973, The American journal of digestive diseases.

[35]  A. Littman Goals and Design , 1971 .

[36]  D. C. Sun,et al.  The Veterans Administration Cooperative Study on Gastric Ulcer. 3. Site and size of the ulcer as determinants of outcome. , 1971, Gastroenterology.

[37]  R. Doll,et al.  Effect of smoking on the production and maintenance of gastric and duodenal ulcers. , 1958, The Lancet.

[38]  H. Necheles,et al.  Peptic ulcer in man. IV. A new antacid made to meet requirements of antacid therapy; chemical and laboratory work. , 1951, The American journal of digestive diseases.